2013
DOI: 10.1074/jbc.m113.461350
|View full text |Cite
|
Sign up to set email alerts
|

Interaction between Her2 and Beclin-1 Proteins Underlies a New Mechanism of Reciprocal Regulation

Abstract: Background: Beclin-1 is one of the essential autophagic proteins. Results: This study identified a novel complex between breast carcinoma Her2 and Beclin-1 that is disrupted by lapatinib, a Her2-tyrosine kinase inhibitor. Conclusion: Lapatinib thwarts the reciprocal cross-regulation between Her2 and Beclin-1, impacting cellular autophagy and Her2 signaling. Significance: The findings elucidate a hitherto unknown association between lapatinib-induced autophagy and the disruption of Her2-Beclin-1 complex.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
50
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 47 publications
(50 citation statements)
references
References 50 publications
0
50
0
Order By: Relevance
“…Beclin 1 was also associated with HER-2, an important biomarker of breast cancer, in a breast cancer microarray dataset analysis; there was a significant association between the loss of Beclin 1 and HER-2 amplification [95]. Of note, Beclin 1 interacts with HER-2 resulting in increased phosphorylation of HER-2 [96]. In breast cancer, other than its role as tumor suppressor and tumor supporter, Beclin 1 is also involved in drug resistance.…”
Section: Expression Of Beclin 1 In Human Breast Cancersmentioning
confidence: 90%
“…Beclin 1 was also associated with HER-2, an important biomarker of breast cancer, in a breast cancer microarray dataset analysis; there was a significant association between the loss of Beclin 1 and HER-2 amplification [95]. Of note, Beclin 1 interacts with HER-2 resulting in increased phosphorylation of HER-2 [96]. In breast cancer, other than its role as tumor suppressor and tumor supporter, Beclin 1 is also involved in drug resistance.…”
Section: Expression Of Beclin 1 In Human Breast Cancersmentioning
confidence: 90%
“…Consistent, lapatinib activates autophagy in breast cancer cells [67] and leukemic cells [68], whereas this has not been reported for trastuzumab. Second, recent work has revealed that HER-2 physically interacts with Beclin 1 in breast cancer cells, although the biological significance of this interaction is unclear [69]. …”
Section: Tyrosine Kinase Inhibitorsmentioning
confidence: 99%
“…Blasticidin selected clones with verified Tet repressor expression were further stably transfected with the linearized Tetinducible plasmids pcDNA4/TO, pcDNA4/TO/lacZ (Invitrogen), or pcDNA4/TO/C325A caspase-9. All procedures involving linearization, transfection, and stable clone selection were carried out as described previously (41)(42)(43).…”
Section: Methodsmentioning
confidence: 99%